Latest BCDA ETF News Today | Earnings, Events & Price Alerts

BCDA News

BioCardia Completes FDA Pre-Submission for Helix Catheter Approval

Feb 10 2026Newsfilter

IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%

Jan 22 2026NASDAQ.COM

BioCardia Completes Third Clinical Consultation with Japan's PMDA for CardiAMP Therapy

Dec 16 2025Newsfilter

BioCardia Elects Marvin Slosman to Board of Directors

Dec 03 2025Newsfilter

BioCardia Enhances Leadership Team by Appointing Farhan Shahab as Vice President of Quality

Nov 24 2025Yahoo Finance

BioCardia, Inc. Reports Smaller Q3 Loss, Surpassing Expectations

Nov 13 2025NASDAQ.COM

BioCardia to Hold Conference Call on November 12, 2025, for Q3 2025 Corporate Update and Financial Results

Nov 06 2025Newsfilter

Gold Declines by More Than 1%; Darden Reports Disappointing Earnings

Sep 18 2025Benzinga

Nasdaq Rises by 100 Points as US Initial Jobless Claims Decrease

Sep 18 2025Benzinga

BioCardia, CART-Tech Partner To Develop Heart3D Fusion Imaging For Interventional Cardiology

Aug 13 2025NASDAQ.COM

BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology

Aug 13 2025Newsfilter

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

Aug 06 2025Newsfilter

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

Aug 06 2025Yahoo Finance

BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter

Aug 04 2025Newsfilter

Henry Ford Health Initiates Patient Enrollment for BioCardia's CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

Jul 16 2025Newsfilter

BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System

Jun 25 2025Newsfilter

BCDA

BCDA

BCDA News

BioCardia Completes FDA Pre-Submission for Helix Catheter Approval

IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%

BioCardia Completes Third Clinical Consultation with Japan's PMDA for CardiAMP Therapy

BioCardia Elects Marvin Slosman to Board of Directors

BioCardia Enhances Leadership Team by Appointing Farhan Shahab as Vice President of Quality

BioCardia, Inc. Reports Smaller Q3 Loss, Surpassing Expectations

BioCardia to Hold Conference Call on November 12, 2025, for Q3 2025 Corporate Update and Financial Results

Gold Declines by More Than 1%; Darden Reports Disappointing Earnings

Nasdaq Rises by 100 Points as US Initial Jobless Claims Decrease

BioCardia, CART-Tech Partner To Develop Heart3D Fusion Imaging For Interventional Cardiology

BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter

Henry Ford Health Initiates Patient Enrollment for BioCardia&#39;s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System

Henry Ford Health Initiates Patient Enrollment for BioCardia's CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction